Archives

New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia 150 150 Shields Health Solutions

New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care 150 150 Shields Health Solutions

Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.
Excelera® Welcomes Experienced Healthcare Executive as National Vice President of Sales 204 115 Shields Health Solutions

Excelera® Welcomes Experienced Healthcare Executive as National Vice President of Sales
Meredith Holt joins Excelera with over 20 years of experience establishing and expanding health care initiatives, programs and relationships.
Excelera Expands Solutions for Members, Manufacturers and Payers, Improving Complex Patient Care in 2019 204 115 Shields Health Solutions

Excelera Expands Solutions for Members, Manufacturers and Payers, Improving Complex Patient Care in 2019
New specialty pharmacy services and products, health system members and top executive hires highlight 2019 accomplishments